Form 4: Tyra Biosciences CEO Acquires Additional Shares Through Employee Stock Purchase Plan

Tyra Biosciences' CEO, Todd Harris, increased his holdings in the company by acquiring 1,241 shares of common stock through the 2021 Employee Stock Purchase Plan.

Summary

• On March 14, 2025, Todd Harris, the President and CEO of Tyra Biosciences, acquired 1,241 shares of common stock.
• The shares were purchased at a price of $9.775 per share through the company's 2021 Employee Stock Purchase Plan.
• Following this transaction, Harris directly owns 1,357,168 shares of Tyra Biosciences common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The CEO's purchase of shares indicates confidence, but it's a relatively small transaction through a standard employee program.

Positives

• The CEO's participation in the Employee Stock Purchase Plan demonstrates confidence in the company's future.

Industry Context

Insider transactions are closely monitored by investors as they can provide insights into management's perspective on the company's prospects. Purchases by executives are often seen as a positive signal.

Stakeholder Impact

• The transaction could have a slightly positive impact on shareholder sentiment.

Key Dates